Tosin Q. Orababa

@tosinorababa.bsky.social

Postdoctoral Research Fellow || AMR and Biofilm infections || Ancientbiotics

This mechanism of action includes bacterial membrane disruption, nucleic acid biosynthesis inhibition via the inhibition of de novo purine and pyrimidine pathway, quorum sensing inhibition, and inhibition of bacterial adhesion (2/n).

BildBildBild

Excited to share our preprint that describes the mechanism of action of an historical infection remedy called Bald’s Eyesalve. In this preprint, we show that Bald’s Eyesalve has multifaceted mechanism of action against both S. aureus and A. baumannii (1/n).

Bild
Freya Harrison@friendlymicrobe.bsky.social · 6mo ago

Remember the medieval remedy we reconstructed years ago? We've now dissected the various ways it attacks and kills bacteria! Preprinted & submitted, led by @tosinorababa.bsky.social & Jess Furner-Pardoe w/ many collaborators #MicroSky #Ancientbiotics www.biorxiv.org/content/10.6...

A cartoon showing the various targets of reconstructed eyesalve against Gram-positive and Gram-negative bacteria. It targets the cell membrane, as well as several intracellular targets including nucleotide biosynthesis. In S. aureus, it also affect quorum sensing.

Excited to share our preprint that describes the mechanism of action of an historical infection remedy called Bald’s Eyesalve. In this preprint, we show that Bald’s Eyesalve has multifaceted mechanism of action against both S. aureus and A. baumannii (1/n).

Bild
Freya Harrison@friendlymicrobe.bsky.social · 6mo ago

Remember the medieval remedy we reconstructed years ago? We've now dissected the various ways it attacks and kills bacteria! Preprinted & submitted, led by @tosinorababa.bsky.social & Jess Furner-Pardoe w/ many collaborators #MicroSky #Ancientbiotics www.biorxiv.org/content/10.6...

A cartoon showing the various targets of reconstructed eyesalve against Gram-positive and Gram-negative bacteria. It targets the cell membrane, as well as several intracellular targets including nucleotide biosynthesis. In S. aureus, it also affect quorum sensing.

Excited to have been selected as an Infection Science Awardee for 2025 by the Microbiology Society. Looking forward to presenting my research at this year’s Federation of Infection Science Conference in Bournemouth.

Microbiology Society@microbiologysociety.org · 8mo ago

🎉 Congratulations to Oluwatosin Orababa @tosinorababa.bsky.social, one of the winners of our 2025 Infection Science Award! 🦠👏 Get to know them in our new interview: microb.io/3XFyCui #InfectionScience #Microbiology #ResearchSpotlight

Photo of Oluwatosin Orababa - Finalist of the 2025 Infection Science Award

Excited to have been selected as an Infection Science Awardee for 2025 by the Microbiology Society. Looking forward to presenting my research at this year’s Federation of Infection Science Conference in Bournemouth.

Microbiology Society@microbiologysociety.org · 8mo ago

🎉 Congratulations to Oluwatosin Orababa @tosinorababa.bsky.social, one of the winners of our 2025 Infection Science Award! 🦠👏 Get to know them in our new interview: microb.io/3XFyCui #InfectionScience #Microbiology #ResearchSpotlight

Photo of Oluwatosin Orababa - Finalist of the 2025 Infection Science Award

Low doses of tEDTA kill P. aeruginosa in models of chronic wound and CF lung #biofilm, but not in a model of endotracheal tube colonisation: preprint from a project led by @tosinorababa.bsky.social and implemented by a crack team of PhD students! #MicroSky www.biorxiv.org/content/10.1...

Low concentrations of tetrasodium EDTA cause significant killing of biofilm-associated P. aeruginosa in high validity models of chronic wound and CF lung infections but not in a model of endotracheal tube colonisation

Pseudomonas aeruginosa is a pathogen notorious for its antimicrobial resistance and is currently classified as a high-priority pathogen for which new drugs are needed. Tetrasodium EDTA (tEDTA) is one of the new antimicrobial compounds that have been shown to have good antibacterial and antibiofilm efficacy against P. aeruginosa. Due to the diversity and highly drug-tolerant nature of P. aeruginosa biofilms in different infection environments, it is important to carry out pre-clinical testing of new antibiofilm agents against this pathogen in media and models that accurately mimic diverse infection environments. In this study, we used different high validity media and biofilm models that mimic chronic wounds, endotracheal tubes, and cystic fibrosis lung infections to assess the efficacy of tEDTA against P. aeruginosa biofilms. We report that different infection environments influence the susceptibility of both planktonic and biofilm forms of P. aeruginosa to tEDTA. The highest tolerance to tEDTA was observed in the media and biofilm model that mimics the endotracheal tube environment. In conclusion, we show that although different infection environments influence the efficacy of tEDTA against P. aeruginosa biofilms, it has good potential for use as an alternative antimicrobial in treating P. aeruginosa-associated biofilm infections. ### Competing Interest Statement The authors have declared no competing interest.

biorxiv.org